HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics

More filters

Study design
Intervention type
Study phase
94studies shown
Showing 1-12 of 94
Other study type icon
RecruitingNCT07066033

Gut microbiome and behavioral factors in children with eating disorders

About this title

A Study of the Intestinal Microbiota in Children and Adolescents With Eating Disorders. A Perspective From Psychoneuroimmunology

Read the official source — NCT07066033
Official study title

Getting Into the Guts of Eating Disorders in Children and Adolescents. A Perspective From Psychoneuroimmunology.

Recruiting in Spain
Eating disordersObservational studyAges 7–18
Countries
Spain
Sponsor
Esther Nova
Drug study icon
RecruitingNCT05511363

KarXT or placebo to prevent relapse of psychosis linked to Alzheimer’s disease

About this titleRead the official source — NCT05511363
Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Recruiting in Spain
SchizophreniaMedication studyAges 55–90
Countries
Spain, United States, France, + 10 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingNCT06540833

Testing ITI-1284 or placebo for psychosis in Alzheimer’s disease

About this titleRead the official source — NCT06540833
Official study title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI 1284 in Patients With Psychosis Associated With Alzheimer's Disease

Recruiting in Spain
SchizophreniaMedication studyAges 55+
Countries
Spain, United States, Bulgaria, + 7 others
Sponsor
Intra-Cellular Therapies, Inc.
Drug study icon
RecruitingNCT06929273

Long-term safety of KarXT in bipolarity type I

What is this study about?

This extension study evaluates the long-term safety and tolerability of KarXT for mania or mania with mixed features in people living with bipolarity type I.

Recruiting in Spain
BipolarityMedicationAges 18–65
Countries
Spain, United States, Australia, + 17 others
Sponsor
Bristol-Myers Squibb (Pharmaceutical company)
Drug study icon
RecruitingNCT06585787

KarXT or placebo for psychosis in Alzheimer’s disease

About this titleRead the official source — NCT06585787
Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Recruiting in Spain
SchizophreniaMedication studyAges 55–90
Countries
Spain, United States, France, + 21 others
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Drug study icon
RecruitingNCT07196501

Osavampator or placebo to maintain depression treatment response

About this titleRead the official source — NCT07196501
Official study title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Maintenance of Effect of NBI-1065845 as an Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)

Recruiting in Spain
DepressionMedication studyAges 18+
Countries
Spain, United States, Australia, + 8 others
Sponsor
Neurocrine Biosciences (Biotech company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.